CliniGA CRO

CliniGA CRO Blog

Separating licence cost from record access during service transfer

Closing a system licence during a provider change can appear to offer immediate savings.

Representative research photograph: Separating licence cost from record access during service transfer
Photo: U.S. Marine Corps photo by Staff Sgt. Sean Potter · License: Public domain · Cropped and resized.
Published
Updated

Closing a system licence during a provider change can appear to offer immediate savings. Data review, query responses or historical record access may still be unfinished, however. Sponsors should not treat commercial licence termination and continued usability of trial records as the same decision during transition planning.

Decision framework

Identify who needs access, for which purpose and for how long. Active editing, read-only review and use of exported records are different requirements. Assess contracts, system capability and retention conditions with appropriate specialists. Do not assume that a file export preserves every function and contextual relationship needed for later review.

Worked example

For example, reports are exported from the outgoing platform and licence closure is proposed. The new team then investigates an open data issue and cannot access its explanatory record. The transition plan tests necessary clarification and review access before closure. This does not mean every user requires unrestricted active access indefinitely.

Implementation checks

  • Define access needs by task, record type and necessary review period before simply counting licences or user accounts.
  • Connect licence termination dates to evidence that the relevant data and record handovers have actually been accepted.
  • Agree how access or explanatory support will be provided if a legitimate question emerges after the service transition.

Acceptance and boundaries

Accept the decision when necessary record use continues while unnecessary permissions can be removed. The cheapest option may not provide suitable access, while the broadest licence is not automatically appropriate either. Commercial and technical owners should assess options together against the actual requirement.

Frequently asked questions

Does an exported PDF solve every access need?
No. Test necessary context, search functions and access to related records separately.
Should all users remain active throughout transition?
Assess permissions proportionately to authorised tasks and genuine operational needs.

Sources

  1. EMA — ICH E6 good clinical practice
  2. WHO — Guidance for best practices for clinical trials